AGAVE-201, A Phase 2, Open-label, Randomized, MulticenterStudy to Evaluate the Efficacy, Safety and Tolerability ofAxatilimab at 3 Different Doses in Patients with Recurrent orRefractory Active Chronic Graft Versus Host Disease who haveReceived at le

Project: Research project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Medicine & Life Sciences